ADCT ADC Therapeutics SA PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

ADC Therapeutics SA (ADCT) Stock: Buy, Sell, or Hold?

$1.44
-0.17 (-10.31%) β–Ό
5d: -12.5% 30d: -1.03% 90d: +42.08%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
47/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.41 – $1.67
Position: SLIGHTLY LOW
Forward P/E & Valuation
-2.4x
Next 12M consensus est.
Wall Street Target
$3.33
+108.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.41 / $1.87
Trend: Uptrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ADCT is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When ADCT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ADCT is currently trading at $1.44, which is considered slightly low relative to its 30-day fair value range of $1.41 to $1.67.

Technical Outlook: Technically, ADCT is in a uptrend. The price is currently testing key support at $1.41. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.3% recently.

Market Sentiment: ADCT scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.33 (+108.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $1.41 - $1.67
Company Quality Score 47/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 52.6%

Trading Range & Key Levels

30-Day Trading Range $1.41 - $1.67
Current vs Trading Range SLIGHTLY LOW
Support Level $1.41
Resistance Level $1.87
Current Trend Uptrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (36/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-10.3%)
  • BULLISH: Trading 108.3% below Wall St target ($3.33)
  • WARNING: Composite score 47/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -2.37
Wall Street Target $3.33 (+108.3%)
Revenue Growth (YoY) 32.2%
Profit Margin -95.7%
Share ADCT Analysis

Share this live ADCT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ADCT)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish trader on StockTwits expresses enthusiasm for $ADCT despite market downturn, citing the Guggenheim presentation as a positive catalyst.
Key Retail Themes: Bullish outlook Positive catalyst
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:05 PM ET
Data refreshes hourly during market hours. Next update: 4:05 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ADCT.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
29 analysts
$208 23 SELL
ALKS
Alkermes Plc
STRONG BUY
20 analysts
$58 41 HOLD
AQST
Aquestive Therapeutics I…
STRONG BUY
9 analysts
$9 62 BUY
TEVA
Teva Pharma Industries L…
STRONG BUY
15 analysts
$49 36 SELL
HROW
Harrow Health Inc
STRONG BUY
9 analysts
$63 51 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ADCT Research Pages
ADCT Technical Chart ADCT Price Prediction ADCT Intrinsic Value DCF ADCT Earnings Date Why is ADCT Moving Today? ADCT Investment Advisor ADCT Fair Price Analyzer ADCT Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals